CONCLUSIONS: Future research should focus on enlarging the sample sizes for tDCS and TMS, and investigating the effect of comorbidities. Neurofeedback lacks significant study quality. It could still be a viable option, particularly for population reluctant to undergo neuromodulation technics. Combination of tDCS and other therapies may hold significant therapeutic potential.
